The Blackstone Group to acquire Takeda Consumer Healthcare Company

Investment firm The Blackstone Group has  entered into a definitive agreement to acquire Takeda Consumer Healthcare Company, the Japanese medicine company. The business is a subsidiary of Takeda Pharmaceutical Company Limited and is most well-known for its flagship vitamin drug Alinamin. Takeda Consumer Healthcare Company also offers a platform of other over-the-counter products, including Benza […]

Read Previous

Base10, Cathay in $12m series-A for Lana

Read Next

Capital Four holds €500,000 first close for its new private debt fund

Most Popular

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.